{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T13:54:19Z","timestamp":1720360459206},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s40478-014-0086-x","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T12:20:32Z","timestamp":1407154832000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Systemic delivery of P42 peptide: a new weapon to fight Huntington\u2019s disease"],"prefix":"10.1186","volume":"2","author":[{"given":"Yoan","family":"Arribat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmina","family":"Talmat-Amar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Paucard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Lesport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Bonneaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Bec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Parmentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Benigno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Larroque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Maurel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Maschat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"issue":"3","key":"9086_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E: Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 2010, 90(3):905\u2013981.","journal-title":"Physiol Rev"},{"issue":"2","key":"9086_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.nurt.2008.01.008","volume":"5","author":"OR Adam","year":"2008","unstructured":"Adam OR, Jankovic J: Symptomatic treatment of Huntington disease. Neurotherapeutics 2008, 5(2):181\u2013197.","journal-title":"Neurotherapeutics"},{"issue":"42","key":"9086_CR3","doi-asserted-by":"publisher","first-page":"41452","DOI":"10.1074\/jbc.M303354200","volume":"278","author":"A Busch","year":"2003","unstructured":"Busch A, Engemann S, Lurz R, Okazawa H, Lehrach H, Wanker EE: Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington\u2019s disease. J Biol Chem 2003, 278(42):41452\u201341461.","journal-title":"J Biol Chem"},{"issue":"2","key":"9086_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1083\/jcb.153.2.283","volume":"153","author":"ST Suhr","year":"2001","unstructured":"Suhr ST, Senut MC, Whitelegge JP, Faull KF, Cuizon DB, Gage FH: Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol 2001, 153(2):283\u2013294.","journal-title":"J Cell Biol"},{"issue":"14","key":"9086_CR5","doi-asserted-by":"publisher","first-page":"9310","DOI":"10.1073\/pnas.152101299","volume":"99","author":"Y Chai","year":"2002","unstructured":"Chai Y, Shao J, Miller VM, Williams A, Paulson HL: Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci U S A 2002, 99(14):9310\u20139315.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"9086_CR6","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1073\/pnas.0400243101","volume":"101","author":"WC Lee","year":"2004","unstructured":"Lee WC, Yoshihara M, Littleton JT: Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington\u2019s disease. Proc Natl Acad Sci U S A 2004, 101(9):3224\u20133229.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9086_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1100\/tsw.2008.60","volume":"8","author":"S Finkbeiner","year":"2008","unstructured":"Finkbeiner S, Mitra S: The ubiquitin-proteasome pathway in Huntington\u2019s disease. Sci World J 2008, 8: 421\u2013433.","journal-title":"Sci World J"},{"issue":"7","key":"9086_CR8","doi-asserted-by":"publisher","first-page":"e68775","DOI":"10.1371\/journal.pone.0068775","volume":"8","author":"Y Arribat","year":"2013","unstructured":"Arribat Y, Bonneaud N, Talmat-Amar Y, Layalle S, Parmentier ML, Maschat F: A huntingtin peptide inhibits polyQ-huntingtin associated defects. PLoS One 2013, 8(7):e68775.","journal-title":"PLoS One"},{"issue":"14","key":"9086_CR9","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1038\/emboj.2010.117","volume":"29","author":"JD Godin","year":"2010","unstructured":"Godin JD, Poizat G, Hickey MA, Maschat F, Humbert S: Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington\u2019s disease. EMBO J 2010, 29(14):2433\u20132445.","journal-title":"EMBO J"},{"issue":"8","key":"9086_CR10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.4161\/auto.6.8.13617","volume":"6","author":"MY Heng","year":"2010","unstructured":"Heng MY, Detloff PJ, Paulson HL, Albin RL: Early alterations of autophagy in Huntington disease-like mice. Autophagy 2010, 6(8):1206\u20131208.","journal-title":"Autophagy"},{"issue":"1","key":"9086_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/hmg\/ddl440","volume":"16","author":"E Rockabrand","year":"2007","unstructured":"Rockabrand E, Slepko N, Pantalone A, Nukala VN, Kazantsev A, Marsh JL, Sullivan PG, Steffan JS, Sensi SL, Thompson LM: The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet 2007, 16(1):61\u201377.","journal-title":"Hum Mol Genet"},{"issue":"43","key":"9086_CR12","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell AL, Ko J, Patterson PH: Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease. J Neurosci 2009, 29(43):13589\u201313602.","journal-title":"J Neurosci"},{"issue":"2","key":"9086_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI45130","volume":"121","author":"DW Sah","year":"2011","unstructured":"Sah DW, Aronin N: Oligonucleotide therapeutic approaches for Huntington disease. J Clin Invest 2011, 121(2):500\u2013507.","journal-title":"J Clin Invest"},{"issue":"42","key":"9086_CR14","doi-asserted-by":"publisher","first-page":"16685","DOI":"10.1073\/pnas.0707842104","volume":"104","author":"V Chopra","year":"2007","unstructured":"Chopra V, Fox JH, Lieberman G, Dorsey K, Matson W, Waldmeier P, Housman DE, Kazantsev A, Young AB, Hersch S: A small-molecule therapeutic lead for Huntington\u2019s disease: preclinical pharmacology and efficacy of C2\u20138 in the R6\/2 transgenic mouse. Proc Natl Acad Sci U S A 2007, 104(42):16685\u201316689.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9086_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neulet.2008.06.015","volume":"449","author":"HA Popiel","year":"2009","unstructured":"Popiel HA, Nagai Y, Fujikake N, Toda T: Delivery of the aggregate inhibitor peptide QBP1 into the mouse brain using PTDs and its therapeutic effect on polyglutamine disease mice. Neurosci Lett 2009, 449(2):87\u201392.","journal-title":"Neurosci Lett"},{"issue":"3","key":"9086_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/81593","volume":"26","author":"I Dragatsis","year":"2000","unstructured":"Dragatsis I, Levine MS, Zeitlin S: Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet 2000, 26(3):300\u2013306.","journal-title":"Nat Genet"},{"issue":"2","key":"9086_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1086\/318207","volume":"68","author":"BR Leavitt","year":"2001","unstructured":"Leavitt BR, Guttman JA, Hodgson JG, Kimel GH, Singaraja R, Vogl AW, Hayden MR: Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo . Am J Hum Genet 2001, 68(2):313\u2013324.","journal-title":"Am J Hum Genet"},{"issue":"Pt 4","key":"9086_CR18","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/brain\/awg077","volume":"126","author":"F Squitieri","year":"2003","unstructured":"Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, Almqvist EW, Turner D, Bachoud-Levi AC, Simpson SA, Delatycki M, Maglione V, Hayden MR, Donato SD: Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 2003, 126(Pt 4):946\u2013955.","journal-title":"Brain"},{"issue":"1","key":"9086_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F: Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004, 118(1):127\u2013138.","journal-title":"Cell"},{"key":"9086_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2202-7-80","volume":"7","author":"JM Van Raamsdonk","year":"2006","unstructured":"Van Raamsdonk JM, Pearson J, Murphy Z, Hayden MR, Leavitt BR: Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease. BMC Neurosci 2006, 7: 80.","journal-title":"BMC Neurosci"},{"issue":"12","key":"9086_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M: Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci 2005, 6(12):919\u2013930.","journal-title":"Nat Rev Neurosci"},{"issue":"22","key":"9086_CR22","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1093\/hmg\/ddn255","volume":"17","author":"B Mugat","year":"2008","unstructured":"Mugat B, Parmentier ML, Bonneaud N, Chan HY, Maschat F: Protective role of Engrailed in a Drosophila model of Huntington\u2019s disease. Hum Mol Genet 2008, 17(22):3601\u20133616.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9086_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP: Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87(3):493\u2013506.","journal-title":"Cell"},{"issue":"4","key":"9086_CR24","doi-asserted-by":"publisher","first-page":"e60012","DOI":"10.1371\/journal.pone.0060012","volume":"8","author":"I Rattray","year":"2013","unstructured":"Rattray I, Smith E, Gale R, Matsumoto K, Bates GP, Modo M: Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/2 mouse model of HD. PLoS One 2013, 8(4):e60012.","journal-title":"PLoS One"},{"issue":"8","key":"9086_CR25","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ: Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J Neurosci 1999, 19(8):3248\u20133257.","journal-title":"J Neurosci"},{"issue":"1","key":"9086_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0958-1669(02)00284-7","volume":"13","author":"JS Wadia","year":"2002","unstructured":"Wadia JS, Dowdy SF: Protein transduction technology. Curr Opin Biotechnol 2002, 13(1):52\u201356.","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"9086_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ncb0304-189","volume":"6","author":"A Joliot","year":"2004","unstructured":"Joliot A, Prochiantz A: Transduction peptides: from technology to physiology. Nat Cell Biol 2004, 6(3):189\u2013196.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"9086_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.addr.2004.10.005","volume":"57","author":"JS Wadia","year":"2005","unstructured":"Wadia JS, Dowdy SF: Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliv Rev 2005, 57(4):579\u2013596.","journal-title":"Adv Drug Deliv Rev"},{"key":"9086_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcis.2013.10.058","volume":"416","author":"A Mouri","year":"2014","unstructured":"Mouri A, Diat O, El Ghzaoui A, Bauer C, Maurel JC, Devoisselle JM, Dorandeu C, Legrand P: Phase behavior of reverse microemulsions based on Peceol((R)). J Colloid Interface Sci 2014, 416: 139\u2013146.","journal-title":"J Colloid Interface Sci"},{"key":"9086_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.nbd.2012.06.026","volume":"48","author":"MA Pouladi","year":"2012","unstructured":"Pouladi MA, Brillaud E, Xie Y, Conforti P, Graham RK, Ehrnhoefer DE, Franciosi S, Zhang W, Poucheret P, Compte E, Maurel JC, Zuccato C, Cattaneo E, Neri C, Hayden MR: NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease. Neurobiol Dis 2012, 48: 282\u2013289.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"9086_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1097-2765(00)80142-2","volume":"2","author":"A Sittler","year":"1998","unstructured":"Sittler A, Walter S, Wedemeyer N, Hasenbank R, Scherzinger E, Eickhoff H, Bates GP, Lehrach H, Wanker EE: SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol Cell 1998, 2(4):427\u2013436.","journal-title":"Mol Cell"},{"issue":"2","key":"9086_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm985","volume":"10","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, Kurosawa M, Nekooki M, Nukina N: Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 2004, 10(2):148\u2013154.","journal-title":"Nat Med"},{"issue":"3","key":"9086_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.nbd.2010.05.014","volume":"39","author":"JA Rodriguez-Navarro","year":"2010","unstructured":"Rodriguez-Navarro JA, Rodriguez L, Casarejos MJ, Solano RM, Gomez A, Perucho J, Cuervo AM, Garcia de Yebenes J, Mena MA: Trehalose ameliorates dopaminergic and tau pathology in parkin deleted\/tau overexpressing mice through autophagy activation. Neurobiol Dis 2010, 39(3):423\u2013438.","journal-title":"Neurobiol Dis"},{"key":"9086_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.addr.2011.12.014","volume":"64","author":"ES Khafagy","year":"2012","unstructured":"Khafagy ES, Morishita M: Oral biodrug delivery using cell-penetrating peptide. Adv Drug Deliv Rev 2012, 64: 531\u2013539.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"9086_CR35","first-page":"813","volume":"33","author":"AM Sieuwerts","year":"1995","unstructured":"Sieuwerts AM, Klijn JG, Peters HA, Foekens JA: The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival. Eur J Clin Chem Clin Biochem 1995, 33(11):813\u2013823.","journal-title":"Eur J Clin Chem Clin Biochem"},{"issue":"3","key":"9086_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.vascn.2006.11.004","volume":"55","author":"DM Drexler","year":"2007","unstructured":"Drexler DM, Garrett TJ, Cantone JL, Diters RW, Mitroka JG, Prieto Conaway MC, Adams SP, Yost RA, Sanders M: Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues. J Pharmacol Toxicol Methods 2007, 55(3):279\u2013288.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"2","key":"9086_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","volume":"219","author":"J Sassone","year":"2009","unstructured":"Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A: Huntington\u2019s disease: the current state of research with peripheral tissues. Exp Neurol 2009, 219(2):385\u2013397.","journal-title":"Exp Neurol"},{"issue":"5","key":"9086_CR38","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"RJ Ferrante","year":"2002","unstructured":"Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM, Beal MF: Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease. J Neurosci 2002, 22(5):1592\u20131599.","journal-title":"J Neurosci"},{"issue":"Pt 16","key":"9086_CR39","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1242\/jcs.126086","volume":"126","author":"M Costanzo","year":"2013","unstructured":"Costanzo M, Abounit S, Marzo L, Danckaert A, Chamoun Z, Roux P, Zurzolo C: Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes. J Cell Sci 2013, 126(Pt 16):3678\u20133685.","journal-title":"J Cell Sci"},{"issue":"12","key":"9086_CR40","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nsmb.1700","volume":"16","author":"S Tam","year":"2009","unstructured":"Tam S, Spiess C, Auyeung W, Joachimiak L, Chen B, Poirier MA, Frydman J: The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation. Nat Struct Mol Biol 2009, 16(12):1279\u20131285.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"9086_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto A, Lucas JJ, Hen R: Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 2000, 101(1):57\u201366.","journal-title":"Cell"},{"issue":"7010","key":"9086_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S: Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431(7010):805\u2013810.","journal-title":"Nature"},{"issue":"7","key":"9086_CR43","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR: Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 2013, 12(7):637\u2013649.","journal-title":"Lancet Neurol"},{"issue":"2","key":"9086_CR44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","volume":"25","author":"MJ Mihm","year":"2007","unstructured":"Mihm MJ, Amann DM, Schanbacher BL, Altschuld RA, Bauer JA, Hoyt KR: Cardiac dysfunction in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 2007, 25(2):297\u2013308.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"9086_CR45","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, Artates JW, Weiss A, Cheng SH, Shihabuddin LS, Hung G, Bennett CF, Cleveland DW: Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron 2012, 74(6):1031\u20131044.","journal-title":"Neuron"},{"issue":"14","key":"9086_CR46","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1074\/jbc.275.14.10437","volume":"275","author":"Y Nagai","year":"2000","unstructured":"Nagai Y, Tucker T, Ren H, Kenan DJ, Henderson BS, Keene JD, Strittmatter WJ, Burke JR: Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. J Biol Chem 2000, 275(14):10437\u201310442.","journal-title":"J Biol Chem"},{"issue":"3","key":"9086_CR47","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1073\/pnas.0408936102","volume":"102","author":"X Zhang","year":"2005","unstructured":"Zhang X, Smith DL, Meriin AB, Engemann S, Russel DE, Roark M, Washington SL, Maxwell MM, Marsh JL, Thompson LM, Wanker EE, Young AB, Housman DE, Bates GP, Sherman MY, Kazantsev AG: A potent small molecule inhibits polyglutamine aggregation in Huntington\u2019s disease neurons and suppresses neurodegeneration in vivo . Proc Natl Acad Sci U S A 2005, 102(3):892\u2013897.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"9086_CR48","doi-asserted-by":"publisher","first-page":"11563","DOI":"10.1073\/pnas.0505321102","volume":"102","author":"WJ Wolfgang","year":"2005","unstructured":"Wolfgang WJ, Miller TW, Webster JM, Huston JS, Thompson LM, Marsh JL, Messer A: Suppression of Huntington\u2019s disease pathology in Drosophila by human single-chain Fv antibodies. Proc Natl Acad Sci U S A 2005, 102(32):11563\u201311568.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"9086_CR49","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1523\/JNEUROSCI.2747-08.2008","volume":"28","author":"AL Southwell","year":"2008","unstructured":"Southwell AL, Khoshnan A, Dunn DE, Bugg CW, Lo DC, Patterson PH: Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity. J Neurosci 2008, 28(36):9013\u20139020.","journal-title":"J Neurosci"},{"issue":"3","key":"9086_CR50","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nbt.1608","volume":"28","author":"PO Bauer","year":"2010","unstructured":"Bauer PO, Goswami A, Wong HK, Okuno M, Kurosawa M, Yamada M, Miyazaki H, Matsumoto G, Kino Y, Nagai Y, Nukina N: Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat Biotechnol 2010, 28(3):256\u2013263.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"9086_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.pneurobio.2011.11.004","volume":"97","author":"DC Butler","year":"2012","unstructured":"Butler DC, McLear JA, Messer A: Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins. Prog Neurobiol 2012, 97(2):190\u2013204.","journal-title":"Prog Neurobiol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-014-0086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-014-0086-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-014-0086-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-014-0086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:14:02Z","timestamp":1630613642000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-014-0086-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9086"],"URL":"https:\/\/doi.org\/10.1186\/s40478-014-0086-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]},"assertion":[{"value":"8 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"86"}}